Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 27 | 5 | 0 | 1 | €25.73 | €40.66 | 58.054% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €58.02 | €78.05 | 34.517% |
| Regeneron Pharmaceuticals Inc. | 38 | 1 | 3 | 0 | €968.60 | €1,000.9 | 3.339% |
| Biogen Inc. | 50 | 1 | 5 | 0 | €216.50 | €293.22 | 35.439% |
| Amgen Inc. | 26 | 0 | 1 | 0 | €279.00 | €297.31 | 6.563% |
| Gilead Sciences Inc | 11 | 1 | 0 | 0 | €60.78 | €84.81 | 39.539% |
| AbbVie Inc. | 23 | 0 | 2 | 0 | €157.50 | €174.43 | 10.751% |
| Eli Lilly Corp. | 52 | 0 | 5 | 0 | €820.90 | €788.80 | -3.910% |
| Merck & Co. Inc. | 30 | 1 | 2 | 0 | €121.00 | €124.97 | 3.284% |
| Abbott Laboratories | 18 | 0 | 2 | 0 | €96.84 | €116.48 | 20.281% |
| Vertex Pharmaceuticals Inc. | 48 | 2 | 4 | 0 | €449.15 | €428.60 | -4.576% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €159.28 | €200.06 | 25.601% |
| Johnson & Johnson | 33 | 1 | 3 | 0 | €135.96 | €195.31 | 43.650% |